
SAROGLITAZAR 4 mg is a prescription medication used to manage non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) with metabolic dysfunction and diabetic dyslipidemia, particularly elevated triglyceride levels in people with type 2 diabetes. It belongs to the PPAR alpha/gamma agonist class and helps improve lipid metabolism, insulin sensitivity, and liver health when combined with a healthy diet and lifestyle changes.
| Generic name | SAROGLITAZAR |
| Strength | 4 mg |
| Manufacturer | Zydus |
| Package size | 45 Tablets |
| Used for | Diabetic dyslipidemia, hypertriglyceridemia, and type 2 diabetes mellitus |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Saroglitazar 4 mg works by activating PPAR-alpha and PPAR-gamma receptors. Activation of PPAR-alpha improves fat metabolism and lowers triglyceride levels, while activation of PPAR-gamma enhances insulin sensitivity and helps regulate blood glucose. Together, these effects improve lipid metabolism and support liver function.